| PERIOD ENDING | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | | Total Revenue | 533,051 | 652,091 | 591,358 | 601,362 | | Cost of Revenue | 210,628 | 277,616 | 251,031 | 246,256 | | | Gross Profit | 322,423 | 374,475 | 340,327 | 355,106 | | | Operating Expenses | | Research Development | 49,295 | 61,216 | 58,564 | 54,641 | | Selling General and Administrative | 160,300 | 201,614 | 177,563 | 178,356 | | Non Recurring | 4,687 | 19,048 | 7,133 |
-
| | Others | 2,612 | 5,122 | 5,111 | 4,716 | | | | Total Operating Expenses | 216,894 | 287,000 | 248,371 |
-
| | | | Operating Income or Loss | 105,529 | 87,475 | 91,956 | 117,393 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,934 | 32,212 | 5,311 | 12,111 | | Earnings Before Interest And Taxes | 107,463 | 119,687 | 97,267 | 129,504 | | Interest Expense | 643 | 991 | 2,174 | 3,845 | | Income Before Tax | 106,820 | 118,696 | 95,093 | 125,659 | | Income Tax Expense | 29,572 | 128,421 | 19,848 | 39,061 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 77,248 | (9,725) | 75,245 | 86,598 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 77,248 | (9,725) | 75,245 | 86,598 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $77,248 | ($9,725) | $75,245 | $86,598 |
|
2.05% Nasdaq 
Income Statement
